Compositions and methods to manufacture tumor suppressor fusions
AssigneeTheraPten Biosciences Inc.
InventorAthanasios Alevizopoulos
Life of this patent
Estimating the term…
Abstract
Provided herein is a fusion protein comprising, or alternatively consisting essentially of, or yet further consisting of an optional signal peptide, a serum albumin, an optional linker, a Phosphatase and Tensin Homolog (PTEN), and an optional purification or detectable marker in any order. Relating polynucleotides, vectors, host cells, pharmaceutical compositions and kits are also disclosed. Further provided are methods for delivering a fusion protein to a subject, treating a cancer or tumor, and/or producing the fusion protein.
Claims29
A fusion protein comprising human serum albumin (HSA) and human Phosphatase and Tensin Homolog (PTEN) tumor suppressor, wherein the HSA is upstream to the PTEN tumor suppressor.
A polynucleotide encoding a fusion protein comprising human serum albumin (HSA) and human Phosphatase and Tensin Homolog (PTEN) tumor suppressor, wherein the HSA is upstream to the PTEN tumor suppressor.
A host cell comprising a polynucleotide that encodes a fusion protein comprising human serum albumin (HSA) and human Phosphatase and Tensin Homolog (PTEN) tumor suppressor, wherein the HSA is upstream to the PTEN tumor suppressor.
Dependencies are inferred from the claim text.